Swanbridge Capital invests in Immagene

Official launch of Immagene: Dutch company developing next-generation immuno-oncology therapeutics   Immagene B.V. launched this month as a private biotech company developing next-generation precision immuno-oncology (IO) treatments. The company based in...

Curie Capital invests in Allero Therapeutics

3 October 2019 Life sciences seed capital fund Curie Capital today announced the closing of a seed investment in Allero Therapeutics, a biopharmaceutical company focused on the development of novel immunotherapies. The company has developed a proprietary platform...

Swanbridge Capital invests in IPaDiC

Rotterdam, July 20th, 2018 – IPaDiC, a private company that aims to develop an implantable insulin pump, announced today that it has secured funding for the first phase of development. The funding allows IPaDiC to develop and validate a prototype of the insulin pump,...